/
Not financial advice. Analytical data for research only.
Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.
Pharmaceutical preparations company · DE · FY ends Dec · 4.94% margin · $105M FCF
Operating margin is thin at 4.94%. Limited cushion if revenue slows or costs rise, not the profile of a wide-moat business.
Insufficient data to identify specific risks. Treat any missing metrics as a data gap, not a clean bill of health.
Profitability & Returns
Revenue (FY)
$190M
Net Income (TTM)
$96M
▲ +111.9% YoY
Op. Margin
4.94%
ROIC
14.43%
▲ +66.9pp YoY
Cash Flow & Balance Sheet
FCF (TTM)
$105M
▲ +167.4% YoY
Op. Cash Flow (TTM)
$106M
▲ +167.7% YoY
Net Debt
-$201M
Net Cash Position
Cash & Equiv.
$256M
Continue Research
SourceComputed from the 10-Q filed 7 May 2026, covering the period ending 31 Mar 2026, as reported to the SEC. Data last refreshed 3 Sept 2026. How this is calculated.
Fiscal year ends Dec. Sector medians are approximate S&P 500 benchmarks and update periodically.